415
Views
26
CrossRef citations to date
0
Altmetric
Original Articles

Improved treatment efficacy of risedronate functionalized chitosan nanoparticles in osteoporosis: formulation development, in vivo, and molecular modelling studies

, ORCID Icon, , ORCID Icon &
Pages 338-355 | Received 09 Jan 2019, Accepted 06 Jun 2019, Published online: 27 Jun 2019
 

Abstract

Delivery of bisphosphonates-like risedronate has been a major challenge till date due to its poor bioavailability and gastrointestinal tract adverse effects. In this study, we explored the prospective use of risedronate functionalised chitosan nanoparticle (RISCN) for management and treatment of osteoporosis. The prepared nanoparticle was characterised by using scanning electron microscopy, atomic force microscopy, and dynamic light scattering technique. Osteoporosis was induced on quarantined female Wistar rats and treated with RISCN. Docking studies were performed to establish the molecular mechanism of RISCN in improving the bone microarchitecture. Results indicated that there was a significant improvement in bone mineral density and healing of trabecular microarchitecture with less cortical porosity on the bone surfaces of the treatment groups. Docking studies indicated a high affinity and binding of chitosan and RISCN towards the human farnesyl diphosphate synthase (FDPS). Thus, a novel risedronate-loaded chitosan nanoparticle revealed promising results in an effective bone bridging process and osteoporosis treatment.

Acknowledgements

Authors appreciatively acknowledge Fleming Laboratories, Hyderabad for providing gift sample of Risedronate sodium. Authors are thankful to Micro and Nano characterisation facility (MNCF), Indian Institute of Science, Bangalore for carrying out SEM and AFM studies. The authors candidly thank M.S.Ramaiah University of Applied Sciences and Gokula Education Foundation (GEF) for supporting with the facilities for the project. The authors wish to thank Dr Ann Mary and Ms Hajira Banu, Faculty of Pharmacy, M.S. Ramaiah University of Applied Sciences for assisting in the language editing process and plagiarism check of the manuscript.

Disclosure statement

No potential conflict of interest was reported by the authors.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.